AI assistant
TITANIUM SANDS LIMITED — Capital/Financing Update 2007
Oct 25, 2007
65956_rns_2007-10-25_f59a7220-437e-4e87-9612-5c002cd62244.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Appendix 3B New issue announcement
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.
Name of entity
Precious Metals Australia Limited (Entity)
ABN
65 009 131 533
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
| 1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the+securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) |
Unlisted employee and executive options to acquire ordinary shares |
|---|---|
| 100,000 Employee and Executive Options | |
| 100,000 employee and executive options exercisable at $3.30 (exp. 13/9/2010) |
|
C:\Documents and Settings\r.wilson\Local Settings\Temporary Internet Files\OLK81\Appendix 3B - New Issue Announcement - 26 October 2007 - LF.doc+ See chapter 19 for defined terms.
Appendix 3B Page 1
1/1/2003
Appendix 3B New issue announcement
-
4 Do the[+] securities rank equally in yes all respects from the date of allotment with an existing[+] class of quoted[+] securities? If the additional securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
-
the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
-
5 Issue price or consideration Nil consideration – employee and executive options
-
6 Purpose of the issue Employee and executive options issued pursuant (If issued as consideration for the to contracts of employment or engagement. acquisition of assets, clearly Issued under the terms and conditions of the PMA identify those assets) Executive and Employee Option Plan.
-
7 Dates of entering[+] securities into 15/10/2007 uncertificated holdings or despatch of certificates
| 8 Number and+class of all+securities quoted on ASX (_including_the securities in clause 2 if applicable) |
Number | +Class |
|---|---|---|
| 102,625,094 | Ordinary fully paid (PMA) |
- See chapter 19 for defined terms.
Appendix 3B Page 2
1/1/2003
Appendix 3B New issue announcement
| 100,000 100,000 125,000 100,000 125,000 125,000 250,000 125,000 125,000 125,000 100,000 125,000 250,000 |
Employee Options Expiring 28 May 2011 exercisable at $1.75 (PMAAS) Employee Options Expiring 28 August 2011 exercisable at $2.00 (PMAAU) Employee Options Expiring 3 September 2009 exercisable at $2.60 (PMAAY) Employee Options Expiring 13 September 2009 exercisable at $2.60 (PMAAW) Employee Options Expiring 26 September 2009 exercisable at $1.50 (PMAAZ) Employee Options Expiring 26 September 2009 exercisable at $1.70 (PMAAZ) Employee Options Expiring 26 September 2011 exercisable at $2.20 (PMAAZ) Employee Options Expiring 30 November 2009 exercisable at $1.95 (PMAAZ) Employee Options Expiring 3 December 2009 exercisable at $2.80 (PMAAZ) Employee Options Expiring 3 March 2010 exercisable at $3.00 (PMA21) Employee Options Expiring 13 January 2010 exercisable at $2.80 (PMA21) Employee Options Expiring 28 February 2010 exercisable at $2.20 (PMA21) Employee and Executive Options Expiring 26 March 2012 exercisable at $2.20 (PMA21) |
|---|---|
- See chapter 19 for defined terms.
Appendix 3B Page 3
1/1/2003
Appendix 3B New issue announcement
| New Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) |
100,000 650,000 125,000 100,000 |
Employee and Executive Options Expiring 13 May 2010 exercisable at $3.00 (PMA21) Ordinary fully paid shares issued 26/06/2007 pursuant to exercise of employee and executive options. Employee and Executive Options Expiring 3 June 2010 exercisable at $3.30 (PMA21) Employee and Executive Options Expiring 13 September 2010 exercisable at $3.30 (C0000000002) |
|---|---|---|
- 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)
Part 2 - Bonus issue or pro rata issue
-
11 Is security holder approval required?
-
11 Is security holder approval required? Not Applicable 12 Is the issue renounceable or nonrenounceable?
-
13 Ratio in which the[+] securities will be offered 14 +Class of +securities to which the offer relates 15 +Record date to determine entitlements
-
16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?
-
17 Policy for deciding entitlements in relation to fractions
-
See chapter 19 for defined terms.
Appendix 3B Page 4
1/1/2003
Appendix 3B New issue announcement
| 18 | Names of countries in which the entity has | Names of countries in which the entity has | Names of countries in which the entity has |
|---|---|---|---|
| +security holders who will not be sent | new | ||
| issue documents | |||
| Note: Security holders must be told how their entitlements | are to | ||
| be dealt with. | |||
| Cross reference: rule 7.7. | |||
| 19 | Closing date for receipt of acceptances | or | |
| renunciations | |||
| 20 | Names of any underwriters | ||
| 21 | Amount of any underwriting fee |
or | |
| commission | |||
| 22 | Names of any brokers to the issue | ||
| 23 | Fee or commission payable to the broker | to | |
| the issue | |||
| 24 | Amount of any handling fee payable | to | |
| brokers who lodge acceptances |
or | ||
| renunciations on behalf of+security holders | |||
| 25 | If the issue is contingent on+security holders’ | ||
| approval, the date of the meeting | |||
| 26 | Date entitlement and acceptance form | and | |
| prospectus or Product Disclosure Statement | |||
| will be sent to persons entitled | |||
| 27 | If the entity has issued options, and the terms | ||
| entitle option holders to participate | on | ||
| exercise, the date on which notices will | be | ||
| sent to option holders | |||
| 28 | Date rights trading will begin (if applicable) | ||
| 29 | Date rights trading will end (if applicable) | ||
| 30 | How do +security holders sell |
their | |
| entitlements_in full_through a broker? | |||
| 31 | How do+security holders sell_part_of | their | |
| entitlements through a broker and accept for | |||
| the balance? | |||
| 32 | How do+security holders dispose of | their |
- See chapter 19 for defined terms.
Appendix 3B Page 5
1/1/2003
Appendix 3B New issue announcement
entitlements (except by sale through a broker)? 33 +Despatch date
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of securities ( tick one )
(a) X Quoted Securities
- (b)[All other securities ]
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
The issue does not form a new class of security
Tick to indicate you are providing the information or documents
35[If the ][+][securities are ][+][equity securities, the names of the 20 largest holders of the ] additional[+] securities, and the number and percentage of additional[+] securities held by those holders
36[If the ][+][securities are ][+][equity securities, a distribution schedule of the additional ][+][securities ] setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over
37[A copy of any trust deed for the additional ][+][securities ]
Entities that have ticked box 34(b)
38 Number of securities for which +quotation is sought
39 Class of +securities for which quotation is sought
- See chapter 19 for defined terms.
Appendix 3B Page 6
1/1/2003
Appendix 3B New issue announcement
40 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted +securities?
If the additional securities do not rank equally, please state:
-
the date from which they do
-
the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
-
the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
41 Reason for request for quotation now
Example: In the case of restricted securities, end of restriction period
on conversion of another security, clearly identify that other security)
42 Number and[+] class of all[+] securities quoted on ASX ( including the securities in clause 38)
Number +Class
Quotation agreement
-
1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.
-
2 We warrant the following to ASX.
-
The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.
-
There is no reason why those[+] securities should not be granted[+] quotation.
-
An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-
Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and
-
See chapter 19 for defined terms.
Appendix 3B Page 7
1/1/2003
Appendix 3B New issue announcement
- that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.
-
We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the[+] securities to be quoted, it has been provided at the time that we request that the[+] securities be quoted.
-
If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.
-
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
-
4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: ________ Date: 26 October 2007 Matthew Lilly Company Secretary
== == == == ==
- See chapter 19 for defined terms.
Appendix 3B Page 8
1/1/2003